Overcoming Barriers to Injectable Therapies: Development of the ORBIT Intervention Within a Behavioural Change Framework

It is estimated among individuals with type 2 diabetes (T2D) requiring injectable therapies to achieve optimal glycaemic control, one-third are reluctant to initiate therapies, with approximately 80% choosing to discontinue or interrupt injectable regimens soon after commencement. Initiation of inje...

Descripción completa

Detalles Bibliográficos
Autores principales: McGuigan, Karen, Hill, Alyson, McCay, Deirdre, O’Kane, Maurice, Coates, Vivien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Clinical Diabetes and Healthcare
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012154/
https://www.ncbi.nlm.nih.gov/pubmed/36994326
http://dx.doi.org/10.3389/fcdhc.2021.792634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012154/
https://www.ncbi.nlm.nih.gov/pubmed/36994326
http://dx.doi.org/10.3389/fcdhc.2021.792634

Ejemplares similares